Colony in Biological Technology
Navigation Links
Colony in Biological Technology
UC Riverside researcher develops novel method to grow human embryonic stem cells
... called Rho-Rock, which the hESCs use during colony formation and which plays an important role in ... pathway, they found, as expected, that the normal colony formation of hESCs was considerably impaired. ... now, it was generally assumed that the hESC colony formation was pivotal for maintaining ...... disease after inhalation. The BNP(TM) technology provided similar colony counts for anthrax in 6 hours as obtained with the traditional Petri method in 24 hours. For Bubonic plague, the BNP(TM) colony count in 24 hours was also similar to what the traditional methodology ...
New designer toxins kill Bt-resistant insect pests
... then teamed up with Tabashnik to test their modified toxins on UA's colony of Bt-resistant pink bollworms, major cotton pests. Team member ... Tim Dennehy and Yves Carrire knew the Bt-resistant pink bollworms in their colony had a mutant version of cadherin. Tabashnik said, "These resistant ...Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
... Indian approvals for Oncology Biopharmaceuticals i.e. GCSF (Granulocyte colony Stimulating Factor), GM-CSF (Granulocyte Macrophage colony Stimulating Factor) and IL-2 (Interleukin-2). For the latter two, Zenotech ...Micromet Closes $80.5 Million Public Offering of Common Stock
... in a phase 1 clinical trial for the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid ...... in a phase 1 clinical trial for the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid ...
Micromet Announces Pricing of Public Offering of Common Stock
... in a phase 1 clinical trial for the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid ...Micromet Announces Public Offering of Common Stock
... in a phase 1 clinical trial for the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid ...... in a phase 1 clinical trial for the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid ...
Micromet Added to Russell 3000 Index
... in a phase 1 clinical trial for the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid ...... a collaboration with Nycomed for the development and commercialization of MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid ...
Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
... a collaboration with Nycomed for the development and commercialization of MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid ...Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...
Scientists discover 'dancing' algae
... matrix about half a millimetre in diameter. Each of the surface cells has two hair-like appendages known as flagella, whose beating propels the colony through the fluid and simultaneously makes them spin about an axis. The researchers found that colonies swimming near a surface can form two types ...... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...
... (psyllium husk). Presented in an enteric-coated, gluten-free, vegetarian gel capsule, each serving of Kibow Biotics contains a total of 30 billion colony forming units (CFU). When taken orally after every meal (3 times) on a daily basis, Kibow Biotics has the potential to help maintain healthy ...
Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...Spiral Biotech to Introduce New Autoplate Spiral Plating System at ASM General Meeting in May
... focuses on automating the pre-analytical and analytical steps involved with traditional microbial enumeration with a product line that includes colony counters, plating systems, anaerobic workstations, susceptibility test software, air samplers and sample prep tools. For more information, contact ...... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...
Micromet to Present at the Cowen Health Care Conference on March 17, 2009
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...Buckyballs could keep water systems flowing
... membranes showed less bacterial attachment than non-treated membranes. After three days, the membranes treated with buckyballs had on average 20 colony forming units, the method by which bacterial colonies are counted. "In contrast, the number of bacterial colonies on the untreated membrane was ...Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...... from biomass. Tuesday, February 17, 2009 6:30 - 9:30 p.m. The Enterprise Center at Foley Hoag, The Bay colony Corporate Center 1000 Winter St., Ste. 4000 Waltham, MA Cost: $25. public $10. students & active military For ...
... which is being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...
Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG
... MT 203 being developed in collaboration with Nycomed. MT 203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...... which is being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...
Micromet to Present at the RBC Capital Markets Healthcare Conference
... which is being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology
... which outlined the methods and techniques used to change one bacterial species, Mycoplasma capricolum, into another, Mycoplasma mycoides Large colony (LC), by replacing one organism's genome with the other one's genome. Genome transplantation was the first essential enabling step in the field of ...Micromet Added to NASDAQ Biotechnology Index
... MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
... of ITMN-191 with the active moiety of polymerase inhibitor R7128 (Roche/Pharmasset) in a 14-day replicon clearance assay and in a 3-week colony formation assay resulted in clearance of the HCV replicon and reduced or suppressed the emergence of drug-resistant viral variants. These ...Micromet, Inc. Reports Third Quarter 2008 Financial Results
... MT 203 being developed in collaboration with Nycomed. MT 203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, ...WEHI Spin-Out MuriGen Restructures G-CSF Antagonist Program With CSL
... Zenyth Therapeutics Limited (now part of CSL Limited) and is developing therapeutic antibodies that inhibit the activity of the cytokine granulocyte colony stimulating factor (G-CSF). The collaboration built on the discovery by Professor Ian Wicks, a clinical rheumatologist at the Walter and Eliza Hall ...... is a MAb with potential to help patients with rheumatoid arthritis. The antibody targets the alpha sub-unit of the granulocyte-macrophage colony stimulating factor receptor (GM-CSFR). CAM-3001 is a phase 1 clinical stage program. -- ICOS - ICOS (Inducible costimulator) is a receptor on ...
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
... Biologics Program -- Completed clinical trial demonstrating the bioequivalence of INS-19, the company's recombinant human granulocyte colony stimulating factor (G-CSF), to Neupogen(R), an FDA-approved G-CSF product for the treatment of neutropenia that recorded 2007 sales of ...Insmed Announces First Quarter 2008 Financial Results
... and Healthcare products Regulatory Agency to initiate a clinical trial for Insmed's most advanced FOB candidate, INS-19 (Granulocyte colony Stimulating Factor or G-CSF), a FOB of the FDA-approved product Neupogen(R), which had U.S. sales of approximately $0.9 billion in ...Other ContentsbirthbirthbirthbirthbirthbirthbirthbirthswitchedswitchedswitchedswitchedswitchedswitchedbabiesbabiesbabiesbabiesbabiesbabiesregulatorregulatorregulatorregulatorregulatorregulatorregulatorregulatorautoimmuneautoimmuneautoimmuneautoimmuneautoimmuneautoimmuneautoimmuneautoimmunepressurepressurepressurepressurepressurepressurepressurepressurepressurepressureairwayairwayairwayairwayairwayautomaticautomaticautomaticautomaticautomaticautomaticautomaticOther TagsFACSaRNA
(Date:11/23/2009)... WI, November 16, 2009 -- A USDOE and USDA study c...dle cropland, and cropland pasture could be conver...al grasses, such as switchgrass, from which biomas...k. Economically viable production of a perennial g... of biomass are removed annually is expected to re...
(Date:11/23/2009)..., N.H. University of New Hampshire microbiologist...115 to advance understanding of the actinorhizal p...nrich nutrient-poor and contaminated soils. , T...awarded Tisa, a professor of molecular, cellular a...mbiotic relationship between the bacteria Frankia ...
(Date:11/23/2009)...sity of Southern California biomedical engineer an... a new tool to help clinicians distinguish cardiac...nic problems manageable with drugs and lifestyle c...serted into the arteries feeding the heart, offer ...f these blood vessels, often revealing deposits of...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 1Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 3September is Vision Safety Month at the Vision Center CHLA 3A Sports Eye Injuries a Leading Cause of Blindness in Children 55422 1September is Vision Safety Month at the Vision Center CHLA 3A Sports Eye Injuries a Leading Cause of Blindness in Children 55422 2September is Vision Safety Month at the Vision Center CHLA 3A Sports Eye Injuries a Leading Cause of Blindness in Children 55422 3Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 1Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 2Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 3Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 4Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 5(Date:11/25/2009)...EACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmealsw...inthegreaterLongBeachareathankstoFaithInAction/Vol...eatHome(IAH),adivisionofSCANHealthPlan.Formorethan...unteerstodeliverwarmThanksgivingmealstoseniorsinne...sAngelesandsurroundingcities. ,, "Ourwarmholida...
(Date:11/25/2009)...dPoliticalEndorsements,Business,andPressJoinEffort...SNewswire/--Onceagain,theNationalBipolarFoundation...rsingtheir"Safe,tilStable"program,whichisnowbeingw...lardisorder.Today,theNationalBipolarFoundationrece...orityMailfromtheLt.GovernorofLouisianaMitchLandrie...
(Date:11/25/2009)... increase blood pressure? This simple question ha...s. New Stress-related gene Modulates High Blood P... pressure? This simple question has been the focu...earch has for the first time established a link be...ure response to stress in mice as well as humans. ...
(Date:11/25/2009)...etfulness could lead mothers to overlook needed ca...HealthDay News) -- A mother,s depression can worse... , Their six-month study of 262 black mothers a...s had more depressive symptoms had more frequent a...er depressive symptoms had less frequent asthma sy...
(Date:11/25/2009)...GTON,Va.,Nov.25/PRNewswire-USNewswire/--TheAmerica...hCareFraudActof2009,"S.2128,whichisdesignedtosubst...fraudinMedicare.ThebillwasintroducedbySen.GeorgeLe...provisionstheAmericanAssociationforHomecareoutline...tionproposedtoCongressinFebruary.Thoseprovisionsin...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Mom's Depression May Worsen Child's Asthma 2Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2[0] SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors[0] First Time-Door is Open for Family Discussion of Bipolar Disorder[0] New stress-related gene modulates high blood pressure in mice and men[0] Mom's Depression May Worsen Child's Asthma[1] American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009'
SortedFACSAltogetheraRNAPoolsPicomolarIMAPTransfluorAcuityXpressMetaXpressIonWorksCyQUANTPhotomultiplierFFPE
Other Tagsthroughout 2throughout 3throughout 4throughout 5throughout 6throughout 7throughout 8throughout 9throughout 10open 2open 3open 4open 5open 6open 7open 8open 9open 10keeping 2keeping 3keeping 4keeping 5keeping 6keeping 7keeping 8keeping 9keeping 10solar 2lack 2lack 3lack 4lack 5lack 6lack 7lack 8lack 9lack 10facts 2each 2each 3each 4each 5each 6each 7each 8each 9each 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |